Category	Topic	Subtopic 	Image	Header 1	Info1	Header2	Info2	Header3	Info3	Header4	Info4	Header5	Info5	Header6	Info6	Header7	Info7			
Retina	General	Layers of the Retina	188_Retina.jpg	How often do photoreceptor outer segments renew?	Every 10 days	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil			
Retina	General	Table of Wavelengths	nil	Rhodopsin most sensitive to?	510nm (green)	L cone?	564-580nm	M cone?	534-545nm	S cone?	420-440nm	nil	nil	nil	nil	nil	nil			
Retina	General	Table of Wavelengths	nil	Excimer laser?	193nm (UV)	Argon retinal laser?	532nm (Green)	Diode laser?	810nm (IR)	Nd:YAG laser?	1064nm	Femtosecond laser?	1053nm	nil	nil	nil	nil			
Retina	General	Bruch's Membrane	nil	"Fusion of RPE and choriocapillaris
5 elements?"	"Basal lamina of RPE
Outer collagenous zone
Elastin fibers
Inner collagenous zone
Basal lamina of choriocapillaris 
(a.k.a. ""Elastin sandwich"")"	Stain with?	PAS (+)	"Choroidal neovascularization occurs within Bruch’s membrane
Outer + Inner Retinal Barriers?"	"Outer = Bruch’s membrane
Inner = Capillary basal lamina"	nil	nil	nil	nil	nil	nil	nil	nil			
Retina	General	Imaging	nil	"Fluorescein angiography (FA)
 _ Fluorescein sodium
   - Absorbs at 465-490nm (blue)
   - Emit at 520-530nm (green)
   - 80% bound to plasma protein
   - 90% renal excretion
 _ Phases
   - Choroidal phase (10-15s)
   - Arterial phase (15-18s)
   - Early arteriovenous phase
   - Arteriovenous phase (20-25s)
   - Recirculation phase (30+s)
   - Late phase (fluorescein leaves retinal circulation by 10min)
 _ Hyperfluorescence
   - Autofluorescence (from lipofuscin)
   - Transmission defect
   - Leaking (increasing blurred border)
   - Pooling (accumulate in anatomic space)
   - Staining (fixed margins)
 _ Hypofluorescence
   - Blocked fluorescence
   - Filling Defect"	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil			
Retina	General	Imaging	nil	"Indocyanine Green Angiography (ICG)
 _ Absorbs at 805m; Emit at 835nm
 _ 98% bound to albumin (stays in choroidal vessels, so better for choroidal circulation)
 _ 5% iodine – avoid if shellfish allergy

Optical Coherence Tomography (OCT)
 _ Time domain: higher bandwidth = higher axial res
 _ Frequency/Spectral domain: faster, better signal-to-noise ratio

Size of:
 _ Foveola?"	0.3mm	 _ Foveal avascular zone?	0.5mm	Location of fovea?	"4mm temporal, 0.8mm inferior to optic nerve"	"Definition of:
 _ Macula?"	>2 GCL layers	 _ Fovea?	only cones present	 _ Foveola?	ONL & GCL absent	nil	nil			
Retina	Macular Diseases	Central Serous Chorioretinopathy (CSCR)	nil	Central Serous Chorioretinopathy (CSCR)	"Idiopathic serous RD w/ multifocal PEDs, RPE changes & mottled atrophy
Usually in young males"	Risks?	"steroids, stress, type A personality"	FA & OCT?	"FA: expansile dot (common), smokestack 
OCT: thickened choroid (?increased hydrostatic pressure in choroid)"	Treatment? 	"Observation (self-limited 3-4mo)
Treat if >3-4mo, recurrent, permanent changes
Laser speeds recovery, not VA outcome
PDT (half-fluence), rifampin, spironolactone"	Ddx of serous RD?		"CNV (+leakage)
PCV (saccular outpouchings)
ON pit (no leakage)
VKH / SO 
posterior scleritis
lymphoma
pre-eclampsia / severe HTN 
choroidal tumor
toxoplasmosis / syphilis"		nil	nil			
Retina	Macular Diseases	Age-Related Macular Degeneration (AMD)	nil	"Dry AMD:
Associated with?"	"age, smoking, positive family history, female, light iris, hyperopia, HTN, hypercholesterolemia"	"Drusen
Hard vs. Soft?"	"Hard: nodular thickening of BM of RPE
Soft: focal PED (separation from Bruch’s)"	Basal Laminar vs. Linear deposits?	"Electron microscopy characterization
BLamD: between plasma & BM of RPE
BLinD: external to BM of RPE"	Size?	"Small <64um
Intermediate 64-124um
Large >124um"	"Geographic Atrophy
Autofluorescence (AF)?"	Decreased AF w/ ring of increased AF predict areas of GA expansion	Ddx of GA?	"Mitochondrial myopathies, central areolar choroidal dystrophy"	nil	nil			
Retina	Macular Diseases	Age-Related Macular Degeneration (AMD)	nil	"Dry AMD:
Cuticular (Basal Laminar) Drusen?"	"Type of early hard drusen (age 30-40s) 
Many small, uniform, demarcated drusen, better seen on FA with “stars-in-the-sky” appearance
May develop large vitelliform detachment"	Reticular Pseudodrusen?	" Interlacing network of 125-250um drusen
 First appear in superotemporal macula
 Better seen on red-free, NOT on FA /ICG
 “Sawtooth” subretinal deposits on OCT"	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil			
Retina	Macular Diseases	Dry AMD	nil	"Dry AMD
 _ Treatment
   AREDS
   - Components? "	"       _ Vitamins C & E, beta carotene, copper, zinc"	"   - 25% reduction in progression to advanced AMD
   - 19% reduction in VA loss over 5 yrs
   - Criteria?"	"       _ Bilateral intermediate (many int or 1 large) 
       _ Unilateral advanced AMD (wet AMD or GA)"	   - Avoid in smokers?	       _ Beta carotene	"   AREDS 2
   - Components? "	"       _ Antioxidants w/o beta carotene
       _ Omega-3 fatty acid
       _ Xanthophylls (zeaxanthine, lutein)"	"   Others
   - Immunomodulation: Copaxone (subQ NSAID)
   - Neuroprotection: Brimonidine (inc BDNF, dec glial activation); CNTF (e.g. secreting liposomes)"	nil	nil	nil	nil	nil			
Retina	Macular Diseases	Dry AMD	nil	"Dry AMD
 _ Epidemiology
   - Framingham Eye Study: 
       _ 6% in age >65
       _ 20% in age>75
 _ Experimental Models
   - Poly (I:C)
   - RIP3 -/-
   - RIP1 -/-
   - CX3CR1 1/1
   - CCL2  -/-
   - RD10"	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil			
Retina	Macular Diseases	Choroidal Neovascularization (CNV)	nil	"Choroidal Neovascularization (CNV)
 _ Classificaton?"	"   Type 1
   - Under RPE
   Type 2
   - Between RPE + photoreceptors
   Type 3
   - Retinal angiomatous proliferations (RAP)"	 _ Classic Definitions?	"   Classic CNV
   - Early hyper + late leakage
   Occult CNV
   - Stippled/granular early hyper + late stain
   - 2 types: fibrovascular PED vs. late leakage of undetermined source
   Types
   - Predominantly Classic (>49% classic)
   - Minimally Classic (<49% classic)
   - Occult w/o Classic (no classic)"	nil	nil	nil	nil	nil	nil	nil	nil					
Retina	Macular Diseases	Choroidal Neovascularization (CNV)	nil	"Retinal Angiomatous Proliferation (RAP)
 _ Yannuzzi Classification?"	"   Stage 1
   - Intraretinal NV / leakage
   Stage 2
   - Subretinal NV + serous PED
   Stage 3
   - Choroidal NV + fibrovascular PED
   - FA: retinochoroidal anastamoses"	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil			
Retina	Macular Diseases	Wet AMD Treatments	nil	"Laser
MPS
- Extrafoveal & Juxtafoveal: 
    _ Laser all (AMD, POHS, idiopathic)
- Subfoveal: (only AMD studied)
    _ <2DD, laser
    _ 2-3.5DD, treat if <20/200
    _ >3.5DD, don’t laser
- Laser only classic, not occult
- Argon = krypton (no difference)"	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil	nil			
Retina	Macular Diseases	Wet AMD Treatments	nil	"PDT
- Regular vs. Reduced fluence? "	"Regular: 600mW/cm2
Reduced: 300mW/cm2

TAP"	PDT > control in classic CNV	VIP	"PDT > control in occult CNV (w/o classic)
Small area (<4DA) and low vision (<20/30)
PDT studies also evaluated myopia"	nil	nil	nil	nil	nil	nil	nil	nil				
Retina	Macular Diseases	Wet AMD Treatments	nil	"Anti-VEGF
- Pegaptanib (Macugen) "	"pegylated anti-VEGF RNA aptamer 
binds VEGF 165
0.3mg"	Ranibizumab (Lucentis)	"48kD Fab of Mab (<50kD to cross retina)
targets VEGF-A
0.3mg (DME), 0.5mg (AMD), 2mg"	Bevacizumab (Avastin)	"full-length Mab + Fc
targets VEGF-A
1.25mg, 2.5mg"	Aflibercept (Eylea)	"ligand-binding domain of VEGFR _ + IgG Fc
binds VEGF-A & placental-like GF
2mg, 4mg"	nil	nil	nil	nil	nil	nil			
Retina	Macular Diseases	Wet AMD Treatments: Studies	nil	VISION	"Macugen q6wks x 48wks > sham
improved VA in all CNV"	MARINA	"Lucentis q4wks x 2yrs > sham
Minimally-classic or occult w/o classic CNV"	ANCHOR	"Lucentis q4wks x 2yrs > PDT q3mo PRN
Predominantly-classic CNV"	PIER	"Lucentis q4wks x 3 then q12wks
Steady decline after 3mo c/w q4wks"	PrONTO	"Lucentis q4wks x 3 then PRN (VA loss + fluid, CRT inc, mac hem, new cl CNV, persistent fluid s/p inj)
Comparable to q4wks; 5.6inj/yr, but q4wk visits
"	SUSTAIN	"Lucentis q4wks x 3 then PRN (VA loss, CRT inc)
Comparable to q4wks; 5.3inj/yr, but q4wk visits
"	HORIZON	"MARINA/ANCHOR/FOCUS pts  tx w/ PRN Lucentis q4wks s/p 2yrs
Continued less frequent dosing -> VA loss"			
Retina	Macular Diseases	Wet AMD Treatments: Studies	nil	CATT	"Lucentis = Avastin q4wks or PRN in VA (<5letter diff)
Lucentis > Avastin q4wks or PRN in OCT fluid (~10%)
Avastin > Lucentis in adverse events (24 vs 19%)"	FOCUS	"Lucentis + PDT > PDT alone
Predominantly-classic CNV"	"SUMMIT (MONT BLANC, DENALI, EVEREST)"	"Lucentis + PDT = Lucentis alone
Except IPCV (Lucentis + PDT > Lucentis)"	CABERNET	Lucentis + epimacular brachy vs Lucentis	RADICAL	"Lucentis + PDT + Dexamethasone vs Lucentis
"	"VIEW1 & 2
"	Eylea q1mo x 3 -> q2mo = Lucentis q1mo	HARBOR	Lucentis 0.5mg q4wks vs PRN vs 2mg q4wks vs PRN			
																				
																				
																				
																				
																				
																				
																				
																				
																				
																				
																				
																				